Company NameATEN Therapeutics Ltd
DirectorsWilfred Sydney Hanna and Ian Abercrombie
Company StatusActive
Company NumberSC547221
CategoryPrivate Limited Company
Incorporation Date7 October 2016(7 years, 5 months ago)

Business Activity

Section MProfessional, scientific and technical activities
SIC 72110Research and experimental development on biotechnology

Directors

Director NameMr Wilfred Sydney Hanna
Date of BirthApril 1967 (Born 57 years ago)
NationalityBritish
StatusCurrent
Appointed01 October 2019(2 years, 11 months after company formation)
Appointment Duration4 years, 6 months
RoleCompany Director
Country of ResidenceEngland
Correspondence Address1 Lochrin Square
92-98 Fountainbridge
Edinburgh
EH3 9QA
Scotland
Director NameMr Ian Abercrombie
Date of BirthJune 1961 (Born 62 years ago)
NationalityScottish
StatusCurrent
Appointed02 February 2022(5 years, 3 months after company formation)
Appointment Duration2 years, 1 month
RoleCEO
Country of ResidenceScotland
Correspondence Address1 Lochrin Square
92-98 Fountainbridge
Edinburgh
EH3 9QA
Scotland
Director NameMr Martin Alexander Quinn
Date of BirthMarch 1970 (Born 54 years ago)
NationalityBritish
StatusResigned
Appointed07 October 2016(same day as company formation)
RoleSolicitor
Country of ResidenceUnited Kingdom
Correspondence AddressWhinnyhall House Kinglassie
Glenrothes
Fife
KY5 0UB
Scotland

Location

Registered Address1 Lochrin Square
92-98 Fountainbridge
Edinburgh
EH3 9QA
Scotland
ConstituencyEdinburgh South West
WardFountainbridge/Craiglockhart
Address MatchesOver 20 other UK companies use this postal address

Accounts

Latest Accounts30 September 2022 (1 year, 6 months ago)
Next Accounts Due30 June 2024 (3 months from now)
Accounts CategorySmall
Accounts Year End30 September

Returns

Latest Return16 October 2023 (5 months, 2 weeks ago)
Next Return Due30 October 2024 (7 months from now)

Filing History

18 October 2023Confirmation statement made on 16 October 2023 with no updates (3 pages)
30 June 2023Accounts for a small company made up to 30 September 2022 (8 pages)
17 October 2022Confirmation statement made on 16 October 2022 with no updates (3 pages)
3 August 2022Current accounting period shortened from 31 October 2022 to 30 September 2022 (1 page)
27 July 2022Accounts for a dormant company made up to 31 October 2021 (2 pages)
15 February 2022Appointment of Mr Ian Abercrombie as a director on 2 February 2022 (2 pages)
26 October 2021Confirmation statement made on 16 October 2021 with updates (4 pages)
27 July 2021Accounts for a dormant company made up to 31 October 2020 (2 pages)
16 October 2020Change of details for Oncobiopharm Limited as a person with significant control on 20 April 2020 (2 pages)
16 October 2020Confirmation statement made on 16 October 2020 with no updates (3 pages)
13 May 2020Accounts for a dormant company made up to 31 October 2019 (2 pages)
24 April 2020Registered office address changed from 1 1 Lochrin Square 92-98 Fountainbridge Edinburgh EH3 9QA Scotland to 1 Lochrin Square 92-98 Fountainbridge Edinburgh EH3 9QA on 24 April 2020 (1 page)
24 April 2020Registered office address changed from Whinnyhall House Kinglassie Glenrothes Fife KY5 0UB Scotland to 1 1 Lochrin Square 92-98 Fountainbridge Edinburgh EH3 9QA on 24 April 2020 (1 page)
4 November 2019Notification of Oncobiopharm Limited as a person with significant control on 1 October 2019 (2 pages)
4 November 2019Termination of appointment of Martin Alexander Quinn as a director on 1 October 2019 (1 page)
4 November 2019Appointment of Mr Wilfred Sydney Hanna as a director on 1 October 2019 (2 pages)
4 November 2019Confirmation statement made on 21 October 2019 with no updates (3 pages)
4 November 2019Cessation of Martin Alexander Quinn as a person with significant control on 1 October 2019 (1 page)
18 July 2019Accounts for a dormant company made up to 31 October 2018 (2 pages)
21 October 2018Confirmation statement made on 21 October 2018 with no updates (3 pages)
11 October 2018Confirmation statement made on 6 October 2018 with no updates (3 pages)
6 June 2018Accounts for a dormant company made up to 31 October 2017 (2 pages)
31 October 2017Confirmation statement made on 6 October 2017 with no updates (3 pages)
31 October 2017Confirmation statement made on 6 October 2017 with no updates (3 pages)
7 October 2016Incorporation
Statement of capital on 2016-10-07
  • GBP 1
  • MODEL ARTICLES ‐ Model articles adopted
(10 pages)
7 October 2016Incorporation
Statement of capital on 2016-10-07
  • GBP 1
  • MODEL ARTICLES ‐ Model articles adopted
(10 pages)